Put Skin Cancer Risk With Hydrochlorothiazide in Perspective

Patients will ask you if they should stop hydrochlorothiazide...based on new labeling that points out increased skin cancer risk.

Growing evidence suggests a link between hydrochlorothiazide and nonmelanoma skin cancer...mostly squamous cell carcinoma.

Photosensitivity with hydrochlorothiazide may play a role.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote